| Serial Number | 97420511 |
| Word Mark | SCRIBE THERAPEUTICS |
| Filing Date | Friday, May 20, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Tuesday, June 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 25, 2023 |
| Goods and Services | Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics, namely, diseases caused by genetic mutations and diseases and disorders for which gene modification would ameliorate or cure; Gene therapy products, namely, biological preparations based on engineered cells for medical use for the treatment of diseases caused by genetic mutations and of diseases and disorders for which gene modification would ameliorate or cure related to immuno-oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics, namely, for the diagnosis, prevention, and treatment of diseases caused by genetic mutations and of diseases and disorders for which gene modification would ameliorate or cure; Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, namely, neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, and pain, and also for the prevention and treatment of cardiovascular, peripheral nervous system, endocrine, gastrointestinal, renal, genetic immunological, hepatic, infectious, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, and hematologic diseases and disorders, and cancer |
| Goods and Services | Molecular diagnostic services in the nature of genetic testing for medical purposes; Medical diagnostic testing services in the field of human disease and human medical conditions |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, and therapeutic products and services; Design and development of engineered cells for use in scientific research and in drug discovery and development; Providing medical and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering; Molecular diagnostic services in the nature of genetic testing for medical research purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 25, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 25, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, October 1, 2020 |
| First Use In Commerce Date | Thursday, October 1, 2020 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 25, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Scribe Therapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Alameda, CA 94501 |
| Party Name | Scribe Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Alameda, CA 94501 |
| Event Date | Event Description |
| Tuesday, May 24, 2022 | NEW APPLICATION ENTERED |
| Wednesday, May 25, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 9, 2023 | ASSIGNED TO EXAMINER |
| Thursday, March 16, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, March 16, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 16, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, March 16, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, March 16, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 5, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 25, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 25, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 20, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sunday, December 10, 2023 | SOU TEAS EXTENSION RECEIVED |
| Sunday, December 10, 2023 | SOU EXTENSION 1 FILED |
| Sunday, December 10, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, December 12, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 11, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 11, 2024 | SOU EXTENSION 2 FILED |
| Tuesday, June 11, 2024 | SOU EXTENSION 2 GRANTED |
| Thursday, June 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |